Treatment of Maladaptive Aggession in Youth Toolkit
Psychotropic agents are increasingly prescribed to youth on an outpatient basis for the treatment of overt aggression, a symptom that may have multiple causes and can be complex and difficult to manage.
The Treatment for Maladaptive Aggression in Youth (T-MAY) consensus development and quality improvement initiative developed this concise reference guide, T-MAY Clinician's Toolkit (PDF, 3.3 MB), a systematic, evidence-based approach that incorporates treatment recommendations developed at a CERTs-convened consensus conference, and other resources.
The T-May Tool Kit is designed to address the difficulties and complexities of treating and managing aggression, and improve outcomes for children and adolescents with maladaptive aggression. The Rutgers CERTs initiated a collaboration with the REsource for Advancing Children's Health Institute (REACH), the New York State Office of Mental Health, the University of Texas at Austin College of Pharmacy, the California Department of Health Care Services, and participating national experts in the fields of policy, research, advocacy and child and adolescent psychiatry to implement the initiative and develop this tool kit for clinicians and other health care providers who work with children and adolescents with maladaptive aggressive behavior.
In June 2012, the journal of the American Academy of Pediatrics published the following two treatment recommendations articles developed from the same consensus development process that developed this tool kit.
Download the toolkit (PDF, 3.3 MB)
Knapp P, Chait A, Pappadopulos E, et al.; on behalf of the T-MAY Steering Group. Treatment of maladaptive aggression in youth: CERT Guidelines I. Engagement, Assessment, an Management. Pediatrics 2012 Jun;129(6):e1562-76. PMID: 22641762.
Scotto Rosato N, Correll CU, Pappadopulos E, et al.; on behalf of the Treatment of Maladaptive Aggression in Youth Steering Committee. Treatment of maladaptive aggression in youth: CERT Guidelines II. Treatments and Ongoing Management. Pediatrics 2012 Jun;129(6):e1577-86. PMID: 22641763.